GTS Securities’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,362
| Closed | -$328K | – | 1276 |
|
|
2024
Q3 | $328K | Buy |
11,362
+3,205
| +39% | +$92.4K | ﹤0.01% | 1283 |
|
|
2024
Q2 | $313K | Buy |
8,157
+2,660
| +48% | +$102K | ﹤0.01% | 1171 |
|
|
2024
Q1 | $323K | Sell |
5,497
-46,550
| -89% | -$2.74M | ﹤0.01% | 992 |
|
|
2023
Q4 | $3.12M | Buy |
52,047
+15,253
| +41% | +$913K | 0.01% | 278 |
|
|
2023
Q3 | $1.4M | Buy |
36,794
+22,465
| +157% | +$855K | ﹤0.01% | 417 |
|
|
2023
Q2 | $1.31M | Buy |
+14,329
| New | +$1.31M | 0.04% | 361 |
|